4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001493152-21-029297
CEO and Director bought 11,187 shares at $5.82 ($65,108)
From the SEC's structured data for this filing
Trades in this filing
Meckler Jeffrey A · CEO and Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-11-18 | Purchase : show line 1 in the form | +11,187 | $5.82 | $65,108 | 25,647 | D |
| Open-market purchases · 11,187 sh · avg $5.82 · $65,108 | ||||||
Loading xslF345X03/ownership.xml…